ometendoОжирение и метаболизмObesity and metabolism2071-87132306-5524Endocrinology Research Centre10.14341/2071-8713-5262ometendo-5262Research ArticleСтатьиArticlesВлияние длительной терапии орлистатом (Ксеникалом) на композиционный состав тела, костный метаболизм и минеральную плотность костной ткани у женщин с ожирением в постменопаузеVliyanie dlitel'noy terapii orlistatom (Ksenikalom) na kompozitsionnyy sostav tela, kostnyy metabolizm i mineral'nuyu plotnost' kostnoy tkani u zhenshchin s ozhireniem v postmenopauzeMel'nichenkoGA-ButrovaS A-Chigar'kovaO V-Il'inA V-20061509200633№3 (2006)3539Copyright © Mel'nichenko G., Butrova S.A., Chigar'kova O.V., Il'in A.V., 20062006Mel'nichenko G., Butrova S.A., Chigar'kova O.V., Il'in A.V.Mel'nichenko G., Butrova S.A., Chigar'kova O.V., Il'in A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.omet-endojournals.ru/jour/article/view/5262ReferencesМельниченко Г.А., Бутрова С.А., Чигарькова О.В., Ильин А.В. Состояние костной ткани у женщин с ожирением в постменопаузе. // Врач. 2004. № 9. С. 32-34.Мельниченко Г.А., Бутрова С.А., Чигарькова О.В., Ильин А.В. Состояние костной ткани у женщин с ожирением в постменопаузе. // Врач. 2004. № 9. С. 32-34.Хорошева Г.А., Мельниченко Г.А., Романцова Т.И., Изможерова Н.В., Попов А.А. Открытое исследование эффективности и безопасности терапии орлистатом (Ксеникалом) у женщин с метаболическим синдромом в постменопаузе. // Ожирение и метаболизм. 2005. № 1. С. 8-12.Хорошева Г.А., Мельниченко Г.А., Романцова Т.И., Изможерова Н.В., Попов А.А. Открытое исследование эффективности и безопасности терапии орлистатом (Ксеникалом) у женщин с метаболическим синдромом в постменопаузе. // Ожирение и метаболизм. 2005. № 1. С. 8-12.Они же. Там же. № 2. С. 26-29.Они же. Там же. № 2. С. 26-29.Рожинская Л.Я. Остеопенический синдром при заболеваниях эндокринной системы и постменопаузальный остеопороз: Дис. … д-ра мед. наук. М., 2001. С. 275.Рожинская Л.Я. Остеопенический синдром при заболеваниях эндокринной системы и постменопаузальный остеопороз: Дис. … д-ра мед. наук. М., 2001. С. 275.Dawson-Hughes B., Shipp C., Sadowski L., Dallal G. Bone density of the radius, spine and hip in relation to percent of ideal body weight in postmenopausal women. Calcif Tissue Int. 1987;40:310-314.Dawson-Hughes B., Shipp C., Sadowski L., Dallal G. Bone density of the radius, spine and hip in relation to percent of ideal body weight in postmenopausal women. Calcif Tissue Int. 1987;40:310-314.Christgau S. Circadian variation in serum Crosslaps concentration is reduced in fasting individuals. Clin Chem. 2000;46:431.Christgau S. Circadian variation in serum Crosslaps concentration is reduced in fasting individuals. Clin Chem. 2000;46:431.Cifuentes M., Riedt C.S., Field M.P., Sherrell R.M., Brolin R.E., Shapses S.A. Weight loss and calcium intake influence calcium absorption in overweight postmenopausal women. Am J Clin Nutr. 2004;80:123-130.Cifuentes M., Riedt C.S., Field M.P., Sherrell R.M., Brolin R.E., Shapses S.A. Weight loss and calcium intake influence calcium absorption in overweight postmenopausal women. Am J Clin Nutr. 2004;80:123-130.Cifuentes, M., Morano A. B., Chowdhury H. A. & Shapses S. A. Energy restriction reduces fractional calcium absorption in mature obese and lean rats. J. Nutr. 2002;132:2660-26667.Cifuentes, M., Morano A. B., Chowdhury H. A. & Shapses S. A. Energy restriction reduces fractional calcium absorption in mature obese and lean rats. J. Nutr. 2002;132:2660-26667.Delmas P.D., Eastell R., Garnero P., Seibel M.J., Stepan J. Committee of Scientific Advisors of the International Osteoporosis Foundation The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int. 2000; 11(Suppl 6): S2-17.Delmas P.D., Eastell R., Garnero P., Seibel M.J., Stepan J. Committee of Scientific Advisors of the International Osteoporosis Foundation The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int. 2000; 11(Suppl 6): S2-17.Gotfredsen A., Westergren Hendel H., Andersen T. Influence of orlistat on bone turnover and body composition. Int J Obes Relat Metab Disord. 2001 Aug; 25(8):1154-60.Gotfredsen A., Westergren Hendel H., Andersen T. Influence of orlistat on bone turnover and body composition. Int J Obes Relat Metab Disord. 2001 Aug; 25(8):1154-60.Hannon R., Eastell R. Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int. 2000; 11(Suppl 6):S30-S44.Hannon R., Eastell R. Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int. 2000; 11(Suppl 6):S30-S44.Holbrook T.L., Barrett-Connor E. The association of lifetime weight and weight control patterns with bone mineral density in an adult community. Bone Miner. 1993;20:141-9.Holbrook T.L., Barrett-Connor E. The association of lifetime weight and weight control patterns with bone mineral density in an adult community. Bone Miner. 1993;20:141-9.Holecki M., Zahorska-Markiewicz B., Nieszporek T., Olszanecka-Glinianowicz M., Mizia-Stec K., Zak-Golab A., Kocelak P., Fryzlewicz-Moska A., Wiecek A. Impact of the mass-reductive therapy with orlistat on 25-(OH)-D3 and PTH concentration in sera of obese, menopausal women. Endokrynol Pol. 2005 May-Jun; 56(3):240-5.Holecki M., Zahorska-Markiewicz B., Nieszporek T., Olszanecka-Glinianowicz M., Mizia-Stec K., Zak-Golab A., Kocelak P., Fryzlewicz-Moska A., Wiecek A. Impact of the mass-reductive therapy with orlistat on 25-(OH)-D3 and PTH concentration in sera of obese, menopausal women. Endokrynol Pol. 2005 May-Jun; 56(3):240-5.Hutton B., Fergusson D. Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet:a systematic review of randomized clinical trials. Am J Clin Nutr. 2004 Dec;80 (6):1461-8.Hutton B., Fergusson D. Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet:a systematic review of randomized clinical trials. Am J Clin Nutr. 2004 Dec;80 (6):1461-8.Lovejoy J.C. The influence of sex hormones on obesity across the female life span. J Wom Health 1998;7:1247-1256.Lovejoy J.C. The influence of sex hormones on obesity across the female life span. J Wom Health 1998;7:1247-1256.Manson J.C. Willet W.C. Stampfer M.J. et al. Body weight and mortality among women. N Engl J. Med 1995;333:677-685.Manson J.C. Willet W.C. Stampfer M.J. et al. Body weight and mortality among women. N Engl J. Med 1995;333:677-685.Milewicz A. Bidzinska B., Sidorowicz A. Perimenopausal obesity. Gynecol Endocrinol. 1996;10:285-291.Milewicz A. Bidzinska B., Sidorowicz A. Perimenopausal obesity. Gynecol Endocrinol. 1996;10:285-291.Nelson H.D, Morris C.D, Kraemer D.F, et al. Osteoporosis in postmenopausalwomen:diagnosis and monitoring. Evidence Report/Technology Assessment No.28 (Prepared by the Oregon Health & Science University Evidence-based PracticeCenter under Contract No. 290-97-0018). AHRQ Publication No. 01-E032.Rockville, MD:Agency for Healthcare Research and Quality. January 2001.Nelson H.D, Morris C.D, Kraemer D.F, et al. Osteoporosis in postmenopausalwomen:diagnosis and monitoring. Evidence Report/Technology Assessment No.28 (Prepared by the Oregon Health & Science University Evidence-based PracticeCenter under Contract No. 290-97-0018). AHRQ Publication No. 01-E032.Rockville, MD:Agency for Healthcare Research and Quality. January 2001.Nguyen TV, Sambrook PN, Eisman JA. Bone loss, physical activity, and weight change in elderly women:the Dubbo Osteoporosis Epidemiology Study. J. Bone Miner Res 1998;13:1458-67.Nguyen TV, Sambrook PN, Eisman JA. Bone loss, physical activity, and weight change in elderly women:the Dubbo Osteoporosis Epidemiology Study. J. Bone Miner Res 1998;13:1458-67.Pace D.G., Blotner S., Guerciolini R. Short-term orlistat treatment does not affect mineral balance and bone turnover in obese men. J. Nutr. 2001;Jun 131(6):1694-9.Pace D.G., Blotner S., Guerciolini R. Short-term orlistat treatment does not affect mineral balance and bone turnover in obese men. J. Nutr. 2001;Jun 131(6):1694-9.Stevenson J.C., Lees B., Devenport M., Cust M.P., Gagner K.F. Determinants of bone density in normal women:risk factors for future osteoporosis? Br. Med. J. 1989;298:924-928.Stevenson J.C., Lees B., Devenport M., Cust M.P., Gagner K.F. Determinants of bone density in normal women:risk factors for future osteoporosis? Br. Med. J. 1989;298:924-928.Slemenda C, Hui SL, Longcope C, Johnston CC. Sex;and bone mass. A study of changes about the time of menopause. Clin Invest. 1987;80:1261-1269.Slemenda C, Hui SL, Longcope C, Johnston CC. Sex;and bone mass. A study of changes about the time of menopause. Clin Invest. 1987;80:1261-1269.
The authors declare that there are no conflicts of interest present.